Tag - pharmaceutical

 
 

PHARMACEUTICAL

JAPAN / Science & Health
Mar 24, 2024
Osaka drugmaker recalls dietary supplements linked to kidney disorders
The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.
Toshiba went private through a takeover bid after a series of battles with activist shareholders.
BUSINESS / Companies
Jan 21, 2024
Management buyouts by big companies on rise in Japan
The total value of management buyout deals exceeded ¥1.4 trillion in Japan in 2023 to hit a record high.
Buyouts by management and controlling parties have surged this year in Japan, with the total value now set to pass ¥1 trillion.
COMMENTARY / Japan
Dec 3, 2023
Being a listed company in Japan is losing its luster
Japan's corporate landscape is shifting as companies opt for management buyouts.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
ASIA PACIFIC
Apr 23, 2022
Questions over effectiveness of COVID remedy costs top Chinese scientist $2 billion
Debate over the efficacy of traditional Chinese medicine has intensified in recent weeks as the nation fights its worst outbreak since the early days of the pandemic.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
JAPAN
Oct 1, 2021
Japan's Takeda says 'human error' caused contamination of Moderna vaccines
Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
COMMENTARY / World
Aug 26, 2020
Pharma rivals are fighting COVID-19 together — Why stop there?
Pandemics make for strange bedfellows.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
BUSINESS / Companies
Dec 17, 2018
Taisho said to near $1.6 billion deal for Bristol-Myers unit
Taisho Pharmaceutical Holdings Co. is nearing a deal to buy Bristol-Myers Squibb Co.'s French over-the-counter unit, people familiar with the matter said, as the Japanese drugmaker seeks to boost its overseas presence.
Rugby / RWC Countdown
Sep 19, 2018
Uehara finds common thread between rugby and business
Akira Uehara, the president of longtime rugby national team sponsor Taisho Pharmaceutical Co., Ltd., played in the front row for Keio University's B.Y.B Rugby Football Club in the 1960s.
BUSINESS
Jul 18, 2018
China heart drug sold globally may have had cancer-linked impurity since 2012
A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’